Document Detail

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.
MedLine Citation:
PMID:  16537378     Owner:  NLM     Status:  MEDLINE    
Neutrophilic airway inflammation is a hallmark of cystic fibrosis (CF). As high oxidant producers, airway neutrophils contribute largely to the systemic redox imbalance seen in CF. In turn, this chronic and profound imbalance can impact circulating neutrophils before their migration into airways. Indeed, in 18 CF patients with stable disease, blood neutrophils were readily deficient in the pivotal antioxidant glutathione (P = 0.003, compared with 9 healthy controls). In a phase 1 study, this deficiency was improved (P = 0.025) by the glutathione prodrug N-acetylcysteine, given orally in high doses (0.6 to 1.0 g three times daily, for 4 weeks). This treatment was safe and markedly decreased sputum elastase activity (P = 0.006), the strongest predictor of CF pulmonary function. Consistently, neutrophil burden in CF airways was decreased upon treatment (P = 0.003), as was the number of airway neutrophils actively releasing elastase-rich granules (P = 0.005), as measured by flow cytometry. Pulmonary function measures were not improved, as expected with short-term treatment. After excluding data from subjects without baseline airway inflammation, positive treatment effects were more pronounced and included decreased sputum IL-8 levels (P = 0.032). Thus, high-dose oral N-acetylcysteine has the potential to counter the intertwined redox and inflammatory imbalances in CF.
Rabindra Tirouvanziam; Carol K Conrad; Teodoro Bottiglieri; Leonore A Herzenberg; Richard B Moss; Leonard A Herzenberg
Related Documents :
10933078 - Frequency and determinants of exaggerated bronchoconstriction during shortened methacho...
9529308 - Effect of inhaled surfactant on pulmonary deposition and clearance of technetium-99m-dt...
15273898 - Bronchodilator responses to metaproterenol sulfate among subjects with spinal cord injury.
3823638 - Gas mixing in the human upper airways.
17576838 - Differential fungicidal activities of amphotericin b and voriconazole against aspergill...
14578568 - Significance of affinity and cooperativity in oxygen binding to hemoglobin of horse fet...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-03-13
Journal Detail:
Title:  Proceedings of the National Academy of Sciences of the United States of America     Volume:  103     ISSN:  0027-8424     ISO Abbreviation:  Proc. Natl. Acad. Sci. U.S.A.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-22     Completed Date:  2006-05-11     Revised Date:  2013-06-07    
Medline Journal Info:
Nlm Unique ID:  7505876     Medline TA:  Proc Natl Acad Sci U S A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4628-33     Citation Subset:  IM    
Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetylcysteine / administration & dosage*
Administration, Oral
Antioxidants / metabolism
Cystic Fibrosis / drug therapy*
Glutathione / analysis,  chemistry,  metabolism*
Neutrophils / drug effects*
Pancreatic Elastase / metabolism
Pneumonia / drug therapy*
Prodrugs / administration & dosage*
Treatment Outcome
Grant Support
Reg. No./Substance:
0/Antioxidants; 0/Prodrugs; 616-91-1/Acetylcysteine; 70-18-8/Glutathione; EC Elastase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduced nitrate leaching and enhanced denitrifier activity and efficiency in organically fertilized ...
Next Document:  Transient receptor potential vanilloid 4 regulates aquaporin-5 abundance under hypotonic conditions.